UnitedHealth Group Sells Brazil Unit for $1.7B

TL;DR

UNH selling Amil in Brazil for $1.7B to focus on US ops.

AI Summary

UnitedHealth Group Inc. announced on March 19, 2024, that it has entered into a definitive agreement to sell its Brazil-based health services business, Amil, to a consortium led by the private equity firm North Haven for approximately $1.7 billion. This divestiture is part of UnitedHealth Group's strategy to focus on its core businesses in the United States.

Why It Matters

This sale allows UnitedHealth Group to streamline its operations and concentrate on its domestic market, potentially improving financial performance and strategic focus.

Risk Assessment

Risk Level: low — The sale of a non-core international asset is a strategic decision with limited immediate risk to the core business.

Key Numbers

• $1.7B — Sale Price (Divestiture of Amil business in Brazil)

Key Players & Entities

• UnitedHealth Group Inc. (company) — Seller
• Amil (company) — Business being sold
• North Haven (company) — Buyer
• $1.7 billion (dollar_amount) — Sale price
• March 19, 2024 (date) — Announcement date

FAQ

From the Filing

0001193125-24-073887.txt : 20240321 0001193125-24-073887.hdr.sgml : 20240321 20240321163058 ACCESSION NUMBER: 0001193125-24-073887 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 22 CONFORMED PERIOD OF REPORT: 20240319 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240321 DATE AS OF CHANGE: 20240321 FILER: COMPANY DATA: COMPANY CONFORMED NAME: UNITEDHEALTH GROUP INC CENTRAL INDEX KEY: 0000731766 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance IRS NUMBER: 411321939 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-10864 FILM NUMBER: 24771838 BUSINESS ADDRESS: STREET 1: UNITEDHEALTH GROUP CENTER STREET 2: 9900 BREN ROAD EAST CITY: MINNEAPOLIS STATE: MN ZIP: 55343 BUSINESS PHONE: 9529361300 MAIL ADDRESS: STREET 1: 9900 BREN ROAD EAST CITY: MINNETONKA STATE: MN ZIP: 55343 FORMER COMPANY: FORMER CONFORMED NAME: UNITED HEALTHCARE CORP/ DATE OF NAME CHANGE: 20000309 FORMER COMPANY: FORMER CONFORMED NAME: UNITED HEALTHCARE CORP DATE OF NAME CHANGE: 19920703 8-K 1 d800516d8k.htm 8-K 8-K UNITEDHEALTH GROUP INC false 0000731766 0000731766 2024-03-19 2024-03-19     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K     Current Report Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 19, 2024     UNITEDHEALTH GROUP INCORPORATED (Exact name of registrant as specified in its charter)       Delaware   1-10864   41-1321939 (State or other jurisdiction of incorporation)   (Commission File Number)   (I.R.S. Employer Identification No.)   UnitedHealth Group Center 9900 Bren Road East Minnetonka , Minnesota   55343 (Address of principal executive offices)   (Zip Code) Registrant’s telephone number, including area code: (952) 936-1300 N/A (Former name or former address, if changed since last report.)     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock, $.01 par value   UNH   New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company  ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐       Item 8.01. Other Events. On March 19, 2024, UnitedHealth Group Incorporated (the “Company”) agreed to sell its (i) 4.600% Notes due April 15, 2027 in the aggregate principal amount of $500,000,000, (ii) 4.700% Notes due April 15, 2029 in the aggregate principal amount of $400,000,000, (iii) 4.900% Notes due April 15, 2031 in the aggregate principal amount of $1,000,000,000, (iv) 5.000% Note